東華大學圖書館 |

Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact./
作者:	Lee, Changhee.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	220 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
Contained By:	Dissertations Abstracts International83-03B.
標題:	Computer engineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28715468
ISBN:	9798538106233

Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact.
Lee, Changhee.

Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 220 p.

Source: Dissertations Abstracts International, Volume: 83-03, Section: B.

Thesis (Ph.D.)--University of California, Los Angeles, 2021.

This item must not be sold to any third party vendors.

Disease progression manifests through a broad spectrum of statically and longitudinally linked clinical features and outcomes. This leads to heterogeneous progression patterns that may vary greatly across individual patients and makes the survival and quality of a patient's life substantially different. Recently, the rapid increase of healthcare databases, such as electronic health records (EHRs) and disease registries, has opened new opportunities for "data-driven" approaches to clinical decision support systems. This dissertation addresses the question of how machine learning (ML) techniques can capitalize on these data resources and provide actionable intelligence to move away from a rules-based clinical care toward a more data-driven and personalized model of care.To this end, we develop a set of data-driven ML frameworks that can better predict and understand disease progression under two broad clinical setups: (I) the static setup where patients' observations are collected at a particular point of time and (II) the longitudinal setup where observations of each patient are repeatedly collected over a period of time. In these setups, we focus on building ML methods that are (i) accurate by providing better performance in predicting disease-related outcomes, (ii) automated by freeing clinicians from the concern of choosing one particular model for a given dataset at hand, and (iii) actionable in a sense that the model is capable of answering "what if" questions and discovering subgroups of patients with similar progression patterns and outcomes.We highlight the following technical contributions. In the static setting, we present a set of novel ML algorithms for survival analysis, a framework that informs the relationships between the clinical features and the events of interest (such as death, onset of a certain disease, etc.), and predicts what type of event will occur and when it will occur. We start off by developing a deep learning (DL) method that makes no modeling assumptions about the underlying survival process and that flexibly allows for competing events. Then, we propose an automated ML for survival analysis that combines the collective intelligence of different survival models to produce a valid survival function that is both discriminative and well-calibrated. Lastly, we develop a DL model that can accurately estimate heterogeneous treatment effects in survival analysis by adjusting for covariate shifts from multiple sources which makes the problem unique and challenging. In the longitudinal setting, we first develop a DL model for dynamic survival analysis which provides personalized and event-specific survival predictions based on a patient's heterogeneous and historical context. Then, we provide a novel temporal clustering method that can transform the raw information in the complex longitudinal observations into clinically relevant and interpretable information to recognize future outcomes as well as life-changing disease manifestations which may cause a patient to transit between clusters.To show the utilities of the proposed models, we evaluate the performance on various real-world medical datasets on breast cancer, prostate cancer, and cystic fibrosis patient cohorts. We demonstrate that the proposed models consistently outperform clinical scores and state-of-the-art ML methods in predicting disease progression, estimating the heterogeneous treatment effects, and providing insights into underlying disease mechanisms.

ISBN: 9798538106233Subjects--Topical Terms:

621879
Computer engineering.
Subjects--Index Terms:

Deep learning

Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact.
LDR:04715nmm a2200373 4500 001 2348634
005 20220912135623.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798538106233
035 $a (MiAaPQ)AAI28715468
035 $a AAI28715468
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lee, Changhee. $3 3688004
245 1 0 $a Machine Learning Frameworks for Data-Driven Personalized Clinical Decision Support and the Clinical Impact.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 220 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
500 $a Advisor: van der Schaar, Mihaela.
502 $a Thesis (Ph.D.)--University of California, Los Angeles, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Disease progression manifests through a broad spectrum of statically and longitudinally linked clinical features and outcomes. This leads to heterogeneous progression patterns that may vary greatly across individual patients and makes the survival and quality of a patient's life substantially different. Recently, the rapid increase of healthcare databases, such as electronic health records (EHRs) and disease registries, has opened new opportunities for "data-driven" approaches to clinical decision support systems. This dissertation addresses the question of how machine learning (ML) techniques can capitalize on these data resources and provide actionable intelligence to move away from a rules-based clinical care toward a more data-driven and personalized model of care.To this end, we develop a set of data-driven ML frameworks that can better predict and understand disease progression under two broad clinical setups: (I) the static setup where patients' observations are collected at a particular point of time and (II) the longitudinal setup where observations of each patient are repeatedly collected over a period of time. In these setups, we focus on building ML methods that are (i) accurate by providing better performance in predicting disease-related outcomes, (ii) automated by freeing clinicians from the concern of choosing one particular model for a given dataset at hand, and (iii) actionable in a sense that the model is capable of answering "what if" questions and discovering subgroups of patients with similar progression patterns and outcomes.We highlight the following technical contributions. In the static setting, we present a set of novel ML algorithms for survival analysis, a framework that informs the relationships between the clinical features and the events of interest (such as death, onset of a certain disease, etc.), and predicts what type of event will occur and when it will occur. We start off by developing a deep learning (DL) method that makes no modeling assumptions about the underlying survival process and that flexibly allows for competing events. Then, we propose an automated ML for survival analysis that combines the collective intelligence of different survival models to produce a valid survival function that is both discriminative and well-calibrated. Lastly, we develop a DL model that can accurately estimate heterogeneous treatment effects in survival analysis by adjusting for covariate shifts from multiple sources which makes the problem unique and challenging. In the longitudinal setting, we first develop a DL model for dynamic survival analysis which provides personalized and event-specific survival predictions based on a patient's heterogeneous and historical context. Then, we provide a novel temporal clustering method that can transform the raw information in the complex longitudinal observations into clinically relevant and interpretable information to recognize future outcomes as well as life-changing disease manifestations which may cause a patient to transit between clusters.To show the utilities of the proposed models, we evaluate the performance on various real-world medical datasets on breast cancer, prostate cancer, and cystic fibrosis patient cohorts. We demonstrate that the proposed models consistently outperform clinical scores and state-of-the-art ML methods in predicting disease progression, estimating the heterogeneous treatment effects, and providing insights into underlying disease mechanisms.
590 $a School code: 0031.
650 4 $a Computer engineering. $3 621879
650 4 $a Health care management. $3 2122906
650 4 $a Datasets. $3 3541416
650 4 $a Experiments. $3 525909
650 4 $a Mortality. $3 533218
650 4 $a Prostate cancer. $3 3561782
650 4 $a Optimization. $3 891104
650 4 $a Patient care planning. $3 3688005
650 4 $a Survival analysis. $3 3566266
650 4 $a Artificial intelligence. $3 516317
653 $a Deep learning
653 $a Healthcare
653 $a Machine learning
653 $a Survival analysis
653 $a Temporal clustering
690 $a 0464
690 $a 0769
690 $a 0800
710 2 $a University of California, Los Angeles. $b Electrical and Computer Engineering 0333. $3 3542511
773 0 $t Dissertations Abstracts International $g 83-03B.
790 $a 0031
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28715468